Failure of naloxone to reverse analgesia from transcutaneous electrical stimulation in patients with chronic pain.
To investigate the possible role of endogenous opiates in the mediation of analgesia produced by low intensity, high frequency transcutaneous electrical stimulation in the presence of chronic pain, an attempt was made to reverse stimulation-induced analgesia with naloxone. Fifteen patients with chronic pain who were consistently relieved of pain by low intensity, high frequency transcutaneous stimulation were studied. During stimulation at 58 Hz, patients were given double-blind intravenous injections of either naloxone (0.4 or 1.2 mg) or saline. Subjective pain ratings were recorded before stimulation, after stimulation, and after naloxone and saline injections. No reversal of analgesia was seen after naloxone or saline. These results suggest that transcutaneous stimulation at low intensity and high frequency may provide analgesia that is not associated with release of endogenous opiates in patients with chronic pain.
D000328:Adult; D000698:Analgesia; D004311:Double-Blind Method; D004599:Electric Stimulation Therapy / Q000379:methods*; D004723:Endorphins / Q000502:physiology; D004745:Enkephalins / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009270:Naloxone / Q000494:pharmacology*; D010148:Intractable Pain / Q000503:physiopathology / Q000628:therapy*
D004723:Endorphins; D004745:Enkephalins; D009270:Naloxone